Alex Goldsmith

Alex Goldsmith is Vice President of Global Scientific Engagement at Flagship Pioneering and supports companies across Flagship’s ecosystem in establishing and building partnerships with scientific and technological innovators around the world.

Alex joined Flagship in 2017, as Principal to Flagship Founder and CEO, Noubar Afeyan, and from 2020 to 2024, served as the Founding Chief Operating Officer of Flagship company Apriori Bio, while also providing strategic and operational leadership across Flagship exploration projects and early-stage companies.

Alex joined Flagship from Pfizer, where he was most recently Head of Business Operations and Strategy for the Medicinal Sciences division, within the company’s Worldwide R&D organization. Before joining Pfizer, he worked at The Boston Consulting Group, advising clients across a range of industries.

Alex holds a Ph.D. in Neurobiology from the University of Cambridge and a first-class honors undergraduate degree in Molecular and Cellular Biochemistry from Oxford University.